The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer
Open accessAbstract
H19 is an imprinted oncofetal non-coding RNA recently shown to be the precursor of miR-675. The pathophysiological roles of H19 and its mature product miR-675 to carcinogenesis have, however, not been defined. By quantitative reverse transcription-polymerase chain reaction, both H19 and miR-675 were found to be upregulated in human colon cancer cell lines and primary human colorectal cancer (CRC) tissues compared with adjacent non-cancerous tissues. Subsequently, the tumor suppressor retinoblastoma (RB) was confirmed to be a direct target of miR-675 as the microRNA suppressed the activity of the luciferase reporter carrying the 3'-untranslated region of RB messenger RNA that contains the miR-675-binding site. Suppression of miR-675 by transfection with anti-miR-675 increased RB expression and at the same time, decreased cell growth and soft agar colony formation in human colon cancer cells. Reciprocally, enhanced miR-675 expression by transfection with miR-675 precursor decreased RB expression, increased tumor cell growth and soft agar colony formation. Moreover, the inverse relationship between the expressions of RB and H19/miR-675 was also revealed in human CRC tissues and colon cancer cell lines. Our findings demonstrate that H19-derived miR-675, through downregulation of its target RB, regulates the CRC development and thus may serve as a potential target for CRC therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
RNAhybrid: microRNA target prediction easy, fast and flexible
Kruger, J., & Rehmsmeier, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl243 · Cited by 1,941
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
Eis, P. S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M. F., Lund, E., & Dahlberg, J. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500613102 · Cited by 1,325
Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 812
MicroRNA expression and function in cancer
Garzon, R., Fabbri, M., Cimmino, A., Calin, G. A., & Croce, C. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.006 · Cited by 780
The H19 Non-Coding RNA Is Essential for Human Tumor Growth
Matouk, I. J., DeGroot, N., Mezan, S., Ayesh, S., Abu-lail, R., Hochberg, A., & Galun, E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000845 · Cited by 650
The imprinted H19 noncoding RNA is a primary microRNA precursor
Cai, X., & Cullen, B. R. (2007) · RNA · doi:10.1261/rna.351707 · Cited by 642
Winawer, S. J., Schottenfeld, D., & Flehinger, B. J. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.4.243 · Cited by 599
miRNAs and apoptosis: RNAs to die for
Jovanovic, M., & Hengartner, M. O. (2006) · Oncogene · doi:10.1038/sj.onc.1209912 · Cited by 510
Systemic Treatment of Colorectal Cancer
Wolpin, B. M., & Mayer, R. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.098 · Cited by 504
Colorectal Cancer Screening: Scientific Review
Walsh, J. M. E., & Terdiman, J. P. (2003) · JAMA · doi:10.1001/jama.289.10.1288 · Cited by 419
The Product of the H19 Gene May Function as an RNA
Brannan, C. I., Dees, E. C., Ingram, R. S., & Tilghman, S. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.1.28-36.1990 · Cited by 400
Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui, H., Onyango, P. O., Brandenburg, S. A., Wu, Y., Hsieh, C., & Feinberg, A. P. (2002) · PubMed · Cited by 387
Berteaux, N., Lottin, S., Monté, D., Pinte, S., Quatannens, B., Coll, J., Hondermarck, H., Curgy, J.-J., Dugimont, T., & Adriaenssens, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504033200 · Cited by 362
Loss of H19 imprinting in esophageal cancer.
Hibi, K., Nakamura, H., Hirai, A., Fujikake, Y., Kasai, Y., Akiyama, S., Ito, K., & Takagi, H. (1996) · PubMed · Cited by 267
Tsang, W. P., & Kwok, T. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210266 · Cited by 188
Self-citationGenetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis
Fearnhead, N. S., Wilding, J. L., & Bodmer, W. F. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.27 · Cited by 179
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
Ariel, I. (2000) · Molecular Pathology · doi:10.1136/mp.53.6.320 · Cited by 146
Examination of IGF2 and H19 Loss of Imprinting in Bladder Cancer
Byun, H., Wong, H., Birnstein, E., Wolff, E. M., Liang, G., & Yang, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0329 · Cited by 133
RB in Breast Cancer: The Crossroads of Tumorigenesis and Treatment
Bosco, E. E., & Knudsen, E. S. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3988 · Cited by 127
Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.
Ariel, I. M., Miao, H., Ji, X., Schneider, T., Roll, D., de Groot, N., Hochberg, A., & Ayesh, S. K. (1998) · Molecular Pathology · doi:10.1136/mp.51.1.21 · Cited by 125
RB, the conductor that orchestrates life, death and differentiation
Khidr, L., & Chen, P.-L. (2006) · Oncogene · doi:10.1038/sj.onc.1209612 · Cited by 123
Possible physiological role of H19 RNA
Ayesh, S. K., Matouk, I., Schneider, T., Ohana, P., Laster, M., Al-Sharef, W. A., de-Groot, N., & Hochberg, A. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10075 · Cited by 120
Expression of the imprinted gene H19 in the human fetus
Lustig, O., Ariel, I., Ilan, J., Lev-Lehman, E., de-Groot, N., & Hochberg, A. (1994) · Molecular Reproduction and Development · doi:10.1002/mrd.1080380302 · Cited by 99
siRNA-mediated gene silencing: a global genome view
Semizarov, D., Kroeger, P., & Fesik, S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh714 · Cited by 78
Unique expression patterns of H19 in human testicular cancers of different etiology
Verkerk, A. J. M. H., Ariel, I., Dekker, M. C., Schneider, T., van Gurp, R. J., GROOT, N. D., Gillis, A., Oosterhuis, J. W., Hochberg, A., & Looijenga, L. H. J. (1997) · Oncogene · doi:10.1038/sj.onc.1200802 · Cited by 65
DeGregori, J. V. (2004) · Journal of Cell Science · doi:10.1242/jcs.01189 · Cited by 60
Lustig, O., Schulze, E., Komitowski, D. D., Erdmann, V. A., Schneider, T., de Groot, N., & Hochberg, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201175 · Cited by 60
Souglakos, J. (2007) · Digestive Diseases · doi:10.1159/000099166 · Cited by 36
Perez, D. S., Handa, R. J., Yang, R. S. H., & Campain, J. A. (2007) · Journal of Applied Toxicology · doi:10.1002/jat.1301 · Cited by 20
Cited by
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Long non-coding RNAs and cancer: a new frontier of translational research?
Spizzo, R., Almeida, M. I., Colombatti, A., & Calin, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.621 · Cited by 1,004
Ren, J., Ding, L., Zhang, D., Shi, G., Xu, Q., Shen, S., Wang, Y., Wang, T., & Hou, Y. (2018) · Theranostics · doi:10.7150/thno.25541 · Cited by 698
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Arun, G., Diermeier, S. D., & Spector, D. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.001 · Cited by 611
Metadata
- Authors
- Tsang, W. P., Ng, E. K. O., Ng, S. S. M., Jin, H., Yu, J., Sung, J. J. Y., & Kwok, T. T.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-19
- Volume
- 31
- Issue
- 3
- Pages
- 350-358
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2111047063
- Cited by
- 456
- References
- 38
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.